Live Breaking News & Updates on Company Publications
Stay updated with breaking news from Company publications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hearing on Online Platforms and market power focussing on the free and Diverse Press. I recognize myself for an opening statement. In recent years, there has been a cascade of competition problems on the internet. Concentration has pushed local journalism to the verge of extincti extinction. The combination of predatory acquisitions and high Network Effects and switching costs undermine entrepreneurship and startup rates. The sheer dominance has resulted in less products leaving people without a competitive alternative of services. In response to these trends, the committee announced we would conduct a bipartisan investigation into competition in the Online Market place. The purpose stoof document anticompetitive conduct online and sense whether our competition sys ....
Good saturday to you. Im richard lui and youre watching msnbc, the place for politics. Just 17 days until voters go to the polls to decide whether president obama deserves another term. Two days until final race off between governor mitt romney and mr. Obama. And 5k, how far ann romney walked today in a Breast CancerCharity Event in florida. Its just a small part of the final sprint to election day. Topping our political headlines today, both president obama and governor romney are off the trail today, focusing instead on debate prep. But their running mates are both on the stump. Congressman paul ryan held rallies in pennsylvania and ohio and the Vice President was in florida. He took aim at mitt romney, saying he has changed his positions more than a couple of times. The president said the day after the romney debate th ....
ALPHARETTA, Ga., April 27, 2023 Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,. | April 27, 2023 ....
23.03.2023 - Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for . ....
RUBY-3, a basket study of povetacicept in autoimmune glomerulonephritis, has initiated patient enrollment; RUBY-4, a basket study of povetacicept in autoimmune cytopenias, targets initiation in Q2. | March 23, 2023 ....